Key result
Brugada syndrome exhibits a distinct ion-channel signature involving 14 differentially expressed genes versus controls.
Why the study?
SCN5A mutations are present in only 20% of Brugada syndrome probands, prompting investigation into whether patients display specific expression patterns for ion channels regulating cardiac conduction, excitability, and repolarization.
Does transcriptional profiling reveal specific ion-channel expression patterns in Brugada syndrome compared to other right ventricular arrhythmogenic diseases and controls?
Observational (n=47)
Does transcriptional profiling reveal specific ion-channel expression patterns in Brugada syndrome compared to other right ventricular arrhythmogenic diseases and controls?
Brugada patients exhibit a common ion-channel molecular expression signature irrespective of the culprit gene, which may have diagnostic and therapeutic implications.
Brugada patients share a distinct ion-channel expression signature irrespective of SCN5A; hypothesis-generating for mechanisms and biomarkers.
AIMS: Brugada syndrome is an inherited sudden-death arrhythmia syndrome. Na(+)-current dysfunction is central, but mutations in the SCN5A gene (encoding the cardiac Na(+)-channel Nav1.5) are present in only 20% of probands. This study addressed the possibility that Brugada patients display specific expression patterns for ion-channels regulating cardiac conduction, excitability, and repolarization. METHODS AND RESULTS: Transcriptional profiling was performed on right-ventricular endomyocardial biopsies from 10 unrelated Brugada probands, 11 non-diseased organ-donors, seven heart-transplant recipients, 10 with arrhythmogenic right-ventricular cardiomyopathy, and nine with idiopathic right-ventricular outflow-tract tachycardia. Brugada patients showed distinct clustering differences vs. the two control and two other ventricular-tachyarrhythmia groups, including 14 of 77 genes encoding important ion-channel/ion-transporter subunits. Nav1.5 and K(+)-channels Kv4.3 and Kir3.4 were more weakly expressed, whereas the Na(+)-channel Nav2.1 and the K(+)-channel TWIK1 were more strongly expressed, in Brugada syndrome. Differences were also seen in Ca(2+)-homeostasis transcripts, including stronger expression of RYR2 and NCX1. The molecular profile of Brugada patients with SCN5A mutations did not differ from Brugada patients without SCN5A mutations. CONCLUSION: Brugada patients exhibit a common ion-channel molecular expression signature, irrespective of the culprit gene. This finding has potentially important implications for our understanding of the pathophysiology of Brugada syndrome, with possible therapeutic and diagnostic consequences.
No takes yet. Share an insight, caveat, or question.
Gaborit et al. (2008) conducted an observational in Brugada syndrome (n=47). Brugada syndrome vs. Controls and other right ventricular arrhythmogenic diseases was evaluated on Transcriptional profiling of ion channel genes. Brugada syndrome patients exhibited a distinct ion-channel expression signature, with differential expression in 14 of 77 genes compared to controls and other tachyarrhythmias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: